Advances in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry

Volumn 62, Issue 9, 2007, Pages 951-953

  Kollins, Scott H ^a   March, John S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DISEASE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GENETIC ASSOCIATION; HUMAN; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 35248873969     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.08.009     Document Type: Note

References (20)

1. Safer D.J. Are stimulants overprescribed for youths with ADHD?. Ann Clin Psychiatry 12 (2000) 55-62
2. Pelham W.E., Foster E.M., and Robb J.A. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr 7 suppl (2007) 121-131
3. Rubia K., Smith A.B., Brammer M.J., and Taylor E. Temporal lobe dysfunction in medication naive boys with Attention Deficit Hyperactivity Disorder during attention allocation and its relation to response variability. Biol Psychiatry 62 (2007) 999-1006
4. Buchmann J., Gierow W., Weber S., Hoeppner J., Klauer T., Benecke R., et al. Restoration of disturbed intracortical motor inhibition and facilitation in ADHD children by methylphenidate. Biol Psychiatry 62 (2007) 963-969
5. Spencer T.J., Biederman J., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., et al. Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane. Biol Psychiatry 62 (2007) 1059-1061
6. van Dyck C.H., Quinlan D.M., Cretella L.M., Staley J.K., Malison R.T., Baldwin R.M., et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 159 (2002) 309-312
7. Chamberlain S.R., Del Campo N., Dowson J., Müller U., Clark L., Robbins T.W., and Sahakian B.J. Atomoxetine improved response inhibition in adults with Attention Deficit Hyperactivity Disorder. Biol Psychiatry 62 (2007) 977-984
8. Sonuga-Barke E.J. Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry 57 (2005) 1231-1238
9. Bidwell L.C., Willcutt E.G., Defries J.C., and Pennington B.F. Testing for neuropsychological endophenotypes in siblings discordant for Attention Deficit Hyperactivity Disorder. Biol Psychiatry 62 (2007) 991-998
10. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., and Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1313-1323
11. Laskey-Su J., Banaschewski T., Buitelaar J., Franke B., Brookes K., Sonuga-Barke E., et al. Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family based association test. Biol Psychiatry 62 (2007) 985-990
12. Shaw P., Gornick M., Lerch J., Addington A., Seal J., Greenstein D., et al. Polymorphisms of the dopamine d4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64 (2007) 921-931
13. Biederman J., Boellner S.W., Childress A., Lopez F.A., Krishnan S., and Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended release in children with ADHD: A double blind, placebo controlled, crossover analog classroom study. Biol Psychiatry 62 (2007) 970-976
14. Coghill D.R., Rhodes S.M., and Matthews K. The neuropsychological effects of chronic methylphenidate on drug naive boys with Attention Deficit Hyperactivity Disorder. Biol Psychiatry 62 (2007) 954-962
15. Jensen P.S., Arnold L.E., Swanson J.M., Vitiello B., Abikoff H.B., Greenhill L.L., et al. 3-Year Follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry 46 (2007) 989-1002
16. Swanson J., Greenhill L., Wigal T., Kollins S., Stehli A., Davies M., et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45 (2006) 1304-1313
17. Swanson J.M., Elliott G.R., Greenhill L.L., Wigal T., Arnold L.E., Vitiello B., et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 46 (2007) 1015-1027
18. Wilens T.E., and Decker M.W. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognition. Biochem Pharmacol (2007) July 7, 2007 [Epub ahead of print].
19. Scahill L., Chappell P.B., Kim Y.S., Schultz R.T., Katsovich L., Shepherd E., et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158 (2001) 1067-1074
20. Findling R.L., McNamara N.K., Stansbrey R.J., Maxhimer R., Periclou A., Mann A., and Graham S.M. A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol 17 (2007) 19-33